Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke
Clinical trial NCT04256473 · COMPLETED
Trial details
- NCT number
- NCT04256473
- Sponsor
- Erasmus Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-10
- Primary completion
- 2022-03-26
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.